Endocrinology, Vol 127, 69-75, Copyright © 1990 by Endocrine Society

ARTICLES

Stimulation of bone matrix apposition in vitro by local growth factors: a comparison between insulin-like growth factor I, platelet-derived growth factor, and transforming growth factor beta

J Pfeilschifter, M Oechsner, A Naumann, RG Gronwald, HW Minne and R Ziegler
Department of Internal Medicine I, University of Heidelberg, West Germany.

Many recent in vitro studies have shown effects of insulin-like growth factor I (IGF I), platelet-derived growth factor (PDGF), and transforming growth factor-beta (TGF beta) on the proliferation and differential functions of bone-forming osteoblasts; however, the question whether these factors might ultimately lead to a net increase or decrease in bone formation has been difficult to assess. In this study, we have used an autoradiographic method based on the incorporation of [3H]proline into freshly synthesized bone matrix to determine the overall effects of these factors on bone matrix apposition in 21-day-old fetal rat calvariae. IGF I, PDGF, and TGF beta increased bone matrix apposition in a dose-dependent manner up to 2- fold within 48 h. In addition, they partially or completely reversed the inhibition of bone matrix apposition observed with PTH. Exogenously added TGF beta was significantly more potent than equimolar concentrations of PDGF or IGF I in stimulating bone formation. Matrix apposition was greatest when IGF I, PDGF, and TGF beta were added simultaneously to the culture medium, indicating that these factors can enhance each other in stimulating bone formation. In conclusion, our results provide direct evidence that IGF I, PDGF, and TGF beta are capable of stimulating bone formation in vitro.

This article has been cited by other articles:

				D.R. Sumner, T.M. Turner, R.M. Urban, A.S. Virdi, and N. Inoue Additive Enhancement of Implant Fixation Following Combined Treatment with rhTGF-beta2 and rhBMP-2 in a Canine Model J. Bone Joint Surg. Am., April 1, 2006; 88(4): 806 - 817. [Abstract] [Full Text] [PDF]

				R. Gopalakrishnan, H. Ouyang, M. J. Somerman, L. K. McCauley, and R. T. Franceschi Matrix {gamma}-Carboxyglutamic Acid Protein Is a Key Regulator of PTH-Mediated Inhibition of Mineralization in MC3T3-E1 Osteoblast-Like Cells Endocrinology, October 1, 2001; 142(10): 4379 - 4388. [Abstract] [Full Text] [PDF]

				A. Wang, J. A. Martin, L. A. Lembke, and R. J. Midura Reversible Suppression of in Vitro Biomineralization by Activation of Protein Kinase A J. Biol. Chem., April 6, 2000; 275(15): 11082 - 11091. [Abstract] [Full Text] [PDF]

				M. Suzawa, Y. Takeuchi, S. Fukumoto, S. Kato, N. Ueno, K. Miyazono, T. Matsumoto, and T. Fujita Extracellular Matrix-Associated Bone Morphogenetic Proteins Are Essential for Differentiation of Murine Osteoblastic Cells in Vitro Endocrinology, May 1, 1999; 140(5): 2125 - 2133. [Abstract] [Full Text]

				S. B. TRIPPEL, R. D. COUTTS, T. A. EINHORN, G. R. MUNDY, and R. G. ROSENFELD Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*{{dagger}} J. Bone Joint Surg. Am., August 1, 1996; 78(8): 1272 - 86. [Full Text]